As per a recent release, the drug lorcaserin (Belviq, Belviq XR) has reportedly been withdrawn by its manufacturing pharmaceutical company Eisai after a warning from the FDA stated that there's a possibility that the drug could increase a person’s risk of cancer.Original Article
You may also like
Insurers Hedge on Trump-Backed Pledge To Improve...
Violence Repeatedly Erupts at Dementia Care Facilities...
Leadership Vacuum: Agencies in New York and Beyond...
A Deloitte-Run System Denied Medicaid Benefits for...
Severely Ill Prisoners Granted Early Release Are Left...
Tempus to buy cancer test maker Personalis for $1.5B
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
